Received Sep 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | UNK | LN4932 | LA |
Injection site swelling, redness, hot, itchiness, and pain. Area enlarged to -12 cm diameter circle; Injection site swelling, redness, hot, itchiness, and pain. Area enlarged to -12 cm diameter circle; Injection site swelling, redness, hot, itchiness, and pain. Area enlarged to -12 cm diameter circle; Injection site swelling, redness, hot, itchiness, and pain. Area enlarged to -12 cm diameter circle; Injection site swelling, redness, hot, itchiness, and pain. Area enlarged to -12 cm diameter circle; Low fever and chills on Day 1-3; Low fever and chills on Day 1-3; This is a spontaneous report received from a Consumer or other non HCP. A 59-year-old male patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 12Sep2025 at 09:00 as dose number unknown, single (Lot number: LN4932) at the age of 59 years, in left arm for immunisation. The patient informed that the facility where vaccine was administered was in doctor's office/urgent care. The patient's relevant medical history included: "drug allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. The patient did not receive any other vaccines on the same date as the vaccine and did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not taking any other medications within 2 weeks of the event starting. The following information was reported: VACCINATION SITE SWELLING (medically significant), VACCINATION SITE ERYTHEMA (medically significant), VACCINATION SITE WARMTH (medically significant), VACCINATION SITE PRURITUS (medically significant), VACCINATION SITE PAIN (medically significant) all with onset 12Sep2025 at 14:30, outcome "not recovered" and all described as "Injection site swelling, redness, hot, itchiness, and pain. Area enlarged to -12 cm diameter circle"; PYREXIA (non-serious), CHILLS (non-serious) all with onset 12Sep2025 at 14:30, outcome "not recovered" and all described as "Low fever and chills on Day 1-3". Therapeutic measures were not taken as a result of vaccination site swelling, vaccination site erythema, vaccination site warmth, vaccination site pruritus, vaccination site pain, pyrexia, chills.
Medical History/Concurrent Conditions: Drug allergy